
Torrent Pharmaceuticals Ltd. share price
NSE: TORNTPHARM · Healthcare
₹4,691.20 +0.45%
Closing price data, updated 17 Nov 2026. 52-week range: -10.6% from high, +27.8% above low.
Price₹4,691.20
Market cap₹1,78,438 Cr
P/E84.0
P/B9.71
ROE27.1%
ROCE9.1%
Debt / equity1.79
Dividend yield0.00%
EPS₹55.84
Book value₹483.03
Operating margin25.0%
Dipscan score43 / 100
Share: WhatsAppX / TwitterTelegram
Torrent Pharmaceuticals Ltd. shareholding pattern
As of Sep 2026: Promoters 60.78%, FIIs 17.22%, DIIs 13.46%, Government 0.00%, Public 6.95%, Others 1.59%.
| Holder | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|---|
| Promoters | 60.78% | 68.31% | 68.31% | 68.31% | 68.31% | 68.31% |
| FIIs | 17.22% | 15.44% | 16.18% | 16.13% | 15.92% | 16.09% |
| DIIs | 13.46% | 9.83% | 9.06% | 9.14% | 9.28% | 8.65% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 6.95% | 5.04% | 4.12% | 4.03% | 4.08% | 4.44% |
| Others | 1.59% | 1.38% | 2.33% | 2.38% | 2.41% | 2.50% |
| No. of Shareholders | 142,140 | 85,776 | 83,811 | 76,214 | 78,226 | 81,856 |
As filed by the company with the exchanges.
Returns
| 1 day | 1 week | 1 month | 3 months | 6 months | 1 year |
|---|---|---|---|---|---|
| +0.45% | -1.24% | +2.43% | -4.54% | +6.52% | +22.62% |
Growth
| Sales growth, 3 years | +13.3% |
| Sales growth, 5 years | – |
| Profit growth, 3 years | +20.2% |
| Profit growth, 5 years | – |
| Latest quarter sales vs last year | +50.8% |
| Latest quarter profit vs last year | -9.6% |
Strengths and weaknesses
Strengths
- Company is expected to give good quarter
- Company has a good return on equity (ROE) track record: 3 Years ROE 26.2%
- Company has been maintaining a healthy dividend payout of 57.8%
Weaknesses
- Stock is trading at 9.71 times its book value
- Promoter holding has decreased over last quarter: -7.53%
- The company has delivered a poor sales growth of 11.8% over past five years.
Peers in Healthcare
| Company | Price | Market cap | P/E | ROE | 1 year |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | ₹1,867.50 | ₹4,48,076 Cr | 40.9 | 14.7% | +8.8% |
| Divi's Laboratories Ltd. | ₹11,080.00 | ₹2,94,139 Cr | 87.5 | 16.2% | +69.4% |
| Apollo Hospitals Enterprise Lt | ₹8,771.00 | ₹1,26,114 Cr | 56.2 | 21.9% | +16.9% |
| Laurus Labs Ltd. | ₹2,220.00 | ₹1,19,949 Cr | 89.5 | 18.2% | +125.2% |
| Zydus Lifesciences Ltd. | ₹1,192.00 | ₹1,18,902 Cr | 28.4 | 19.7% | +27.0% |
| Dr. Reddy's Laboratories Ltd. | ₹1,377.90 | ₹1,14,778 Cr | 41.0 | 12.1% | +13.7% |
| Cipla Ltd. | ₹1,394.50 | ₹1,12,658 Cr | 38.9 | 11.8% | -8.0% |
| Mankind Pharma Ltd. | ₹2,626.60 | ₹1,08,490 Cr | 48.4 | 12.5% | +18.3% |
Frequently asked questions
What is the share price of Torrent Pharmaceuticals Ltd.?
Torrent Pharmaceuticals Ltd. (TORNTPHARM) last closed at ₹4,691.20 (+0.45% on the day).
What is the market cap of Torrent Pharmaceuticals Ltd.?
About ₹1,78,438 Cr.
What is the P/E ratio of Torrent Pharmaceuticals Ltd.?
The price-to-earnings ratio is 84.0, and return on equity is 27.1%.
Figures are calculated from company results and exchange prices and are for information only.